Vindesine is a vinca alkaloid antineoplastic agent that functions as a microtubule inhibitor by binding to tubulin, preventing polymerization and arresting cell division during the M phase of the cell… Read more
Vindesine is a vinca alkaloid antineoplastic agent that functions as a microtubule inhibitor by binding to tubulin, preventing polymerization and arresting cell division during the M phase of the cell cycle. This chemotherapy medication is primarily utilized in combination regimens to treat various malignancies, including leukemias, lymphomas, melanoma, breast cancer, and lung cancer. This category provides essential pharmaceutical reference standards required for rigorous quality control and analytical testing of the drug substance. Laboratories rely on these high-quality materials, including the parent API, its sulfate salt, and specific pharmacopeial and non-pharmacopeial impurities, to perform accurate impurity profiling and method validation. The inclusion of stable isotope labelled compounds further supports the development of precise quantitative assays, ensuring that pharmaceutical manufacturing processes meet stringent regulatory requirements for both efficacy and safety.